The potential anchor tenant, a biotech firm based in the innovation district, is being recruited by other cities.

Global biopharmaceutical company Gilead Sciences Inc. (Nasdaq: GILD) is closing its office in Seattle and laying off 72 ...

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

When City Manager Aaron Busch attended his first Biotech International conference as a member of the city’s staff, he found ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

Trinity Biotech plc (Nasdaq: TRIB) (the "Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report ...

"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...